Lucy Therapeutics


Lucy Therapeutics is leading the change in how we think about mitochondria and the intersecting pathways that play critical roles in human health and disease. Focused initially on diseases of the central nervous system (CNS), such as Parkinson’s disease or Rett syndrome, our vision is to create a world in which mitochondrial-involved diseases can be halted the moment they are diagnosed. 

See all Members